- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹568.7b
Operates as a pharmaceutical company in India.
500488
₹26,763.45
7D
4.1%
1Y
-22.7%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹413.9b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,443.10
7D
1.1%
1Y
-24.8%
Sanofi India
Market Cap: ₹77.3b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,355.45
7D
-3.5%
1Y
-44.1%